TB-500 vs Thymosin Alpha-1
Side-by-side comparison of TB-500, Thymosin Alpha-1 — mechanism, dosing, half-life, side effects, and research status.
| Attribute | TB-500 Thymosin Beta-4 Synthetic Analogue Recovery | Thymosin Alpha-1 Thymosin Alpha-1 (Tα1) Longevity |
|---|---|---|
| Basics | ||
| Molecular type | Thymic Peptide Analogue | Thymic Peptide |
| Amino acids | 43 | 28 |
| Molecular weight | 4,921 Da | 3,108.4 Da |
| Half-life | Long-acting (days) | ~2 hours |
| Route(s) | Subcutaneous, Intramuscular | Subcutaneous |
| Mechanism & Research | ||
| Primary mechanism | TB-500's primary mechanism involves binding to G-actin (monomeric actin) through its conserved LKKTETQ sequence. By sequestering actin, it regulates cytoskeletal dynamics in ways that promote cell migration — a critical … | Thymosin Alpha-1 stimulates T-cell differentiation and maturation, particularly enhancing T-helper cell (Th1) responses. This drives improved cell-mediated immunity — the arm of the immune system responsible for clearing… |
| Research status | Research Compound | Research Compound |
| Evidence summary | TB-500 research spans cardiac regeneration, wound healing, hair follicle regeneration, and musculoskeletal repair. Most data is preclinical. Phase 1/2 trials with native Thymosin Beta-4 for cardiac indications have been … | Thymosin Alpha-1 has extensive human clinical data from its regulatory approval in Asia and Europe for viral hepatitis and cancer adjunct therapy. Longevity applications build on this established safety and immune-modula… |
| Protocol & Dosing | ||
| Typical dose | 5–10 mg per injection | 1.6 mg per injection (standard clinical dose) |
| Frequency | 2x per week (loading), then weekly | 2x per week for 6–12 weeks |
| Duration | 4–8 weeks | 6–12 weeks |
| Timing | No specific timing requirement | Any time of day |
| Safety | ||
| Common side effects |
|
|
| Contraindications |
|
|
| Anti-doping | Prohibited (WADA S2) | Not Prohibited |
| Deeper reading | ||
| Related peptides | BPC-157, GHK-Cu, Thymosin Alpha-1 | Epithalon, TB-500, LL-37 |
| Full profile | Read full TB-500 profile → | Read full Thymosin Alpha-1 profile → |
Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.